MED: Medifast Inc. Average Forecast Price

Symbol and logo of brand Medifast, Inc (MED)

Medifast, Inc. (MED) enjoys high audience loyalty due to effective weight loss methodologies and a high-quality diet. The business relies on the closed OPTAVIA nutrition system and a network of mentors, which allows the company to maintain premium margins. However, the expansion of new obesity drugs has created risks, leaving operating income at 11.98. This chart of the consolidated forecast value serves as an assessment tool and is presented below.

MED (Medifast, Inc) Analyst Consensus Forecast history from 07/04/2022 to 11/11/2026

OPTAVIA (MED) - metric breakdowns and financial figures

- market price and analyst price targets:
Stock Quotes medifastinc.com|MED - Analyst Consensus Forecast
- market capitalization information:
Market Value OPTAVIA|MED - Enterprise Value
- shareholders' equity book value data:
Equity per Share Medifast|MED - Book Capitalization|Market Capitalization to Net Assets medifastinc.com|MED - Company Total Assets
- debt obligations and liquidity statistics:
Total Debt to Capital Coefficient Medifast, Inc.|MED - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Medifast, Inc|MED - Company Debts|Debt to Book Value Ratio OPTAVIA|MED - Company Long-Term Debts|Short-Term Debt Medifast|Interim Coverage Ratio medifastinc.com
- net income and valuation multiples indicators:
MED - Company Net Income|Company Profit Forecast Medifast, Inc.|MED - Price to Earnings Ratio|Projected Price to Earnings Medifast Inc.|MED - PEG Multiple|Company Value to EBITDA OPTAVIA|MED - Operating profit EBITDA|Earnings per share for the last 12 months Medifast|MED - Net earnings per share (EPS TTM)|Year-over-year net earnings per share change for the last twelve months medifastinc.com|MED - Earnings growth in current year|Net earnings per share change forecast for next year Medifast, Inc.
Fundamental company analysis:medifastinc.com (MED)
Core merchandise of Medifast Inc.

Medifast, Inc. (MED) is expanding its presence in the sports nutrition and longevity segments, seeking to reduce market cyclicality through product portfolio diversification. This indicator measures the fair value of shares adjusted for inflation and rates, capturing fundamental business shifts, which allows investors to timely recognize a downward asset valuation trend via the current consensus target price.

Competing companies

Consensus Target amersports.com AS|Analyst Consensus Forecast PLNT (Planet Fitness)|Life Time Group Holdings, Inc. (LTH) - Average Forecast Price|Peloton Interactive Inc - Analyst Consensus Forecast|OSW (OneSpaWorld Ltd) - Broker Consensus Forecast|HLF: Analyst Consensus Forecast|Forecast Levels Chart XPOF (xponential.com)|AIRS (elitebodysculpture.com) - Analyst Consensus Forecast|Huami Corporation (ZEPP) - Analyst Median Target|Consensus Target WW (WW International)|Analyst Forecast Prices FTLF|Price Target Chart Escalade, Incorporated ESCA|FCHL: Broker Consensus Forecast|Beachbody - Analyst Consensus Forecast|Average Forecast Price Mannatech, Incorporated|Allurion Technologies Inc (ALUR) - Price Target Chart|PMNT - Analyst Median Target|Price Target Chart Fitell Corp.|FORME (TRNR) - Analyst Median Target|Price Target Chart Smart for Life (SMFL)